Details of the Drug Reposition

General Information of This Drug (ID: DMVJL8W)

Drug Name
RG6299   DMVJL8W
Drug Type
Antisense oligonucleotide

Information on Drug Reposition of This Drug

Molecular Interaction Atlas (MIA)
2 Phase 2 Indication(s)
Indication Name Indication ID ICD-11 Status REF
Geographic atrophy DIS4Q1R7 9B75 Phase 2 [1]
IgA nephropathy DISZ8MTK MF8Y Phase 2 [1]
------------------------------------------------------------------------------------

References

1 Clinical pipeline report, company report or official report of Roche